- This event has passed.
February 1, 2020 @ 2:00 pm - 3:30 pm
Magic City Books is thrilled to welcome two-time Pulitzer Prize winning Wall Street Journal reporter and bestselling author John Carreyrou in celebration of the paperback release of his book, Bad Blood, a gripping story of the biggest corporate fraud since Enron—a tale of ambition and hubris set amid the bold promises of Silicon Valley.
John Carreyrou will be in conversation with the President of OU-Tulsa and Tulsa Literary Coalition board member, Dr. John Schumann.
This is a ticketed event, each ticket includes one copy of Bad Blood and two seats at the event on Saturday February 1 at the Schusterman Library on the campus of OU-Tulsa (4502 E. 41st Street). There is a limit of four tickets per person/email address.
Ticket holders will be able to pick up their books and event wristbands for entry to the event at Magic City Books starting on Tuesday, January 28.
About Bad Blood:
The Financial Times & McKinsey Business Book of the Year
A New York Times Notable Book
A Washington Post Notable Book
One of the Best Books of the Year: NPR, San Francisco Chronicle, Time, Esquire, Fortune, Marie Claire, GQ, Mental Floss, Science Friday, Bloomberg, Popular Mechanics, BookRiot, The Seattle Times, The Oregonian, Publishers Weekly, Library Journal
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.